81 related articles for article (PubMed ID: 9407440)
1. Heterogeneity of angiotensin action in renal circulation.
Ito S; Amin J; Ren Y; Arima S; Abe K; Carretero OA
Kidney Int Suppl; 1997 Dec; 63():S128-31. PubMed ID: 9407440
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics.
Arima S
Clin Exp Nephrol; 2003 Sep; 7(3):172-8. PubMed ID: 14586712
[TBL] [Abstract][Full Text] [Related]
3. Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin II.
Steinhausen M; Ballantyne D; Fretschner M; Hoffend J; Parekh N
Kidney Int Suppl; 1990 Nov; 30():S55-9. PubMed ID: 2259077
[TBL] [Abstract][Full Text] [Related]
4. [The contribution of endogenous vasodilators to the control of glomerular hemodynamics].
Arima S; Ito S; Abe K
Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):692-701. PubMed ID: 8084069
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.
Ito S; Arima S; Ren YL; Juncos LA; Carretero OA
J Clin Invest; 1993 May; 91(5):2012-9. PubMed ID: 8486771
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow.
Juncos LA; Ren Y; Arima S; Garvin J; Carretero OA; Ito S
Kidney Int; 1996 Feb; 49(2):374-81. PubMed ID: 8821820
[TBL] [Abstract][Full Text] [Related]
7. Distinct modulation of superficial and juxtamedullary arterioles by prostaglandin in vivo.
Matsuda H; Hayashi K; Arakawa K; Kubota E; Honda M; Tokuyama H; Suzuki H; Yamamoto T; Kajiya F; Saruta T
Hypertens Res; 2002 Nov; 25(6):901-10. PubMed ID: 12484515
[TBL] [Abstract][Full Text] [Related]
8. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole.
Endo Y; Arima S; Yaoita H; Omata K; Tsunoda K; Takeuchi K; Abe K; Ito S
Kidney Int Suppl; 1997 Dec; 63():S205-7. PubMed ID: 9407460
[TBL] [Abstract][Full Text] [Related]
9. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
10. Moderate intrarenal vasoconstriction after high pressor doses of norepinephrine in the rat: comparison with effects of angiotensin II.
Badzyńska B; Sadowski J
Kidney Blood Press Res; 2011; 34(5):307-10. PubMed ID: 21606652
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney.
Murakami M; Matsuda H; Kubota E; Wakino S; Honda M; Hayashi K; Saruta T
Kidney Int Suppl; 1997 Dec; 63():S132-5. PubMed ID: 9407441
[TBL] [Abstract][Full Text] [Related]
12. Renal arteriolar angiotensin responses during varied adenosine receptor activation.
Carmines PK; Inscho EW
Hypertension; 1994 Jan; 23(1 Suppl):I114-9. PubMed ID: 8282342
[TBL] [Abstract][Full Text] [Related]
13. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus.
Schoonmaker GC; Fallet RW; Carmines PK
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F302-9. PubMed ID: 10662734
[TBL] [Abstract][Full Text] [Related]
14. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways.
Imig JD; Deichmann PC
Am J Physiol; 1997 Aug; 273(2 Pt 2):F274-82. PubMed ID: 9277588
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists.
Inscho EW; Carmines PK; Navar LG
Am J Physiol; 1990 Jul; 259(1 Pt 2):F157-63. PubMed ID: 2115739
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
17. Compromised renal microvascular reactivity of angiotensin type 1 double null mice.
Park S; Bivona BJ; Harrison-Bernard LM
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F60-7. PubMed ID: 17409281
[TBL] [Abstract][Full Text] [Related]
18. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
19. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.
Kohagura K; Arima S; Endo Y; Chiba Y; Ito O; Abe M; Omata K; Ito S
Hypertens Res; 2001 Sep; 24(5):551-7. PubMed ID: 11675950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
